AndhraNews.net
Home » Business News » 2014 » February » February 28, 2014

DSM issues long-term €500 million bond


February 28, 2014 - London

Royal DSM, the global Life Sciences and Materials Sciences company, has successfully issued a €500 million 2.375% bond due 2024.

The proceeds will be used to refinance the €500 million bond maturing on 17 March 2014.

The terms are laid down in the €4 billion Debt Issuance Program of Royal DSM, the final terms and the supplements thereto, which are available on the Investor Relations website.

The re-offer price was 99.555%. Based on this price the yield is 2.425%. The bond will be listed on Euronext Amsterdam shortly.

This release does not constitute an offer or an invitation to subscribe for or purchase any securities. The notes are being offered only by means of a prospectus.

DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 24,500 employees deliver annual net sales of around €10 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.

Or find us on:      

For more information:

DSM Corporate Communications

Herman Betten
tel. +31 (0) 45 5782017
e-mail media.relations@dsm.com

DSM Investor Relations

Dave Huizing
tel. +31 (0) 45 5782864
e-mail investor.relations@dsm.com
Press release-pdf



This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM N.V. via Globenewswire

HUG#1765428

GlobeNewswire

Comment on this story

Share